Orexin A depolarises rat intergeniculate leaflet neurons through non‐selective cation channels

2019 ◽  
Vol 50 (4) ◽  
pp. 2683-2693
Author(s):  
Katarzyna Palus‐Chramiec ◽  
Lukasz Chrobok ◽  
Mariusz Kepczynski ◽  
Marian Henryk Lewandowski
2015 ◽  
Vol 10 (S 01) ◽  
Author(s):  
M Freichel ◽  
D Schumacher ◽  
C Matka ◽  
I Mathar ◽  
U Kriebs ◽  
...  
Keyword(s):  

2005 ◽  
Vol 43 (05) ◽  
Author(s):  
JJ Tebbe ◽  
N Tükengün ◽  
R Arnold ◽  
MKH Schäfer
Keyword(s):  

Author(s):  
Dariia Dryn ◽  
Mariia Melnyk ◽  
Ihor Kizub ◽  
Hongzhen Hu ◽  
Anatoly I. Soloviev ◽  
...  

GYNECOLOGY ◽  
2020 ◽  
Vol 22 (1) ◽  
pp. 50-54
Author(s):  
Zukhra Kh. Ebzieva ◽  
Svetlana V. Yureneva ◽  
Tatiana Yu. Ivanets

Aim. To conduct a comparative analysis of serum orexin A levels in women of different age periods with and without sleep disorder and vasomotor symptoms. To evaluate the dynamics of orexin A levels under menopausal hormone therapy. Materials and methods. The study included 50 postmenopausal women and 30 women of reproductive age with a regular menstrual cycle. Using block randomization, patients are divided into 3 groups: group 1 (main group), n=25, -STRAW+ 10 (+1b and +1c), patients with sleep disorder and vasomotor symptoms; group 2 (comparison group), n=25, STRAW+ 10 (+1b and +1c), patients with vasomotor symptoms without sleep disorder; group 3 (control group), n=30, STRAW+ 10 (-4), women of reproductive age without sleep disorder. Group 1 patients were given menopausal hormone therapy. A comparative analysis was carried out using the questionnaire for assessing menopausal symptoms severity by the Greene Scale (the Greene Climacteric Scale) and Rating Scale for subjective sleep characteristics. After 12 weeks of treatment, a control examination was performed. Results. In group 1 women, the serum orexin A levels were significantly higher compared to the women without the symptoms. The link between the orexin A levels and menopause syndrome severity was established. A significant decrease in the menopausal symptoms severity after 12 weeks of menopausal hormone therapy was shown. It was accompanied by a 1,3-fold decrease in orexin A levels. Conclusions. The obtained data indicate the possible role of orexin A and the orexin neuropeptide system in the pathogenesis of sleep disorder and vasomotor symptoms in postmenopausal women.


1994 ◽  
Vol 251 (2-3) ◽  
pp. 119-125 ◽  
Author(s):  
He Zhang ◽  
Masato Inazu ◽  
Bryce Weir ◽  
Michael Buchanan ◽  
Ed Daniel

Biomolecules ◽  
2021 ◽  
Vol 11 (7) ◽  
pp. 1021
Author(s):  
Carla Abrahamian ◽  
Christian Grimm

Microphthalmia-associated transcription factor (MITF) is the principal transcription factor regulating pivotal processes in melanoma cell development, growth, survival, proliferation, differentiation and invasion. In recent years, convincing evidence has been provided attesting key roles of endolysosomal cation channels, specifically TPCs and TRPMLs, in cancer, including breast cancer, glioblastoma, bladder cancer, hepatocellular carcinoma and melanoma. In this review, we provide a gene expression profile of these channels in different types of cancers and decipher their roles, in particular the roles of two-pore channel 2 (TPC2) and TRPML1 in melanocytes and melanoma. We specifically discuss the signaling cascades regulating MITF and the relationship between endolysosomal cation channels, MAPK, canonical Wnt/GSK3 pathways and MITF.


2021 ◽  
pp. 147603
Author(s):  
Lukasz Chrobok ◽  
Anna Alwani ◽  
Kamil Pradel ◽  
Jasmin Daniela Klich ◽  
Marian Henryk Lewandowski
Keyword(s):  
Orexin A ◽  

Sign in / Sign up

Export Citation Format

Share Document